At the ASCO (American Society of Oncology) 2024 Annual General Meeting in Chicago commencing 31st May to June 4th, Imugene has been selected to present poster session 157A.
Abstract TPS2687 is titled -
Combination therapy with the oncolytic virus CF33-CD19 and blinatumomab for the treatment of advanced solid tumors
https://meetings.asco.org/abstracts-presentations/238317
The poster will be presented by Dr Daneng Li from City of Hope Comprehensive Cancer Centre
Abstract details will be available online on 31st May.
There is sure to lots of eyes on this presentation.
GLTAH - Go Team Imugene
.
At the ASCO (American Society of Oncology) 2024 Annual General...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |